table of content
1 Introduction to Research & Analysis Reports
1.1 Neglected Tropical Diseases Drugs and Vaccine Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Neglected Tropical Diseases Drugs and Vaccine Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Neglected Tropical Diseases Drugs and Vaccine Overall Market Size
2.1 Global Neglected Tropical Diseases Drugs and Vaccine Market Size: 2021 VS 2028
2.2 Global Neglected Tropical Diseases Drugs and Vaccine Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Neglected Tropical Diseases Drugs and Vaccine Players in Global Market
3.2 Top Global Neglected Tropical Diseases Drugs and Vaccine Companies Ranked by Revenue
3.3 Global Neglected Tropical Diseases Drugs and Vaccine Revenue by Companies
3.4 Top 3 and Top 5 Neglected Tropical Diseases Drugs and Vaccine Companies in Global Market, by Revenue in 2021
3.5 Global Companies Neglected Tropical Diseases Drugs and Vaccine Product Type
3.6 Tier 1, Tier 2 and Tier 3 Neglected Tropical Diseases Drugs and Vaccine Players in Global Market
3.6.1 List of Global Tier 1 Neglected Tropical Diseases Drugs and Vaccine Companies
3.6.2 List of Global Tier 2 and Tier 3 Neglected Tropical Diseases Drugs and Vaccine Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global Neglected Tropical Diseases Drugs and Vaccine Market Size Markets, 2021 & 2028
4.1.2 Malaria
4.1.3 Ebola
4.1.4 Dengue
4.1.5 Chagas
4.1.6 Leishmaniasis
4.1.7 Other
4.2 By Type - Global Neglected Tropical Diseases Drugs and Vaccine Revenue & Forecasts
4.2.1 By Type - Global Neglected Tropical Diseases Drugs and Vaccine Revenue, 2017-2022
4.2.2 By Type - Global Neglected Tropical Diseases Drugs and Vaccine Revenue, 2023-2028
4.2.3 By Type - Global Neglected Tropical Diseases Drugs and Vaccine Revenue Market Share, 2017-2028
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Neglected Tropical Diseases Drugs and Vaccine Market Size, 2021 & 2028
5.1.2 Drugs
5.1.3 Vaccines
5.2 By Application - Global Neglected Tropical Diseases Drugs and Vaccine Revenue & Forecasts
5.2.1 By Application - Global Neglected Tropical Diseases Drugs and Vaccine Revenue, 2017-2022
5.2.2 By Application - Global Neglected Tropical Diseases Drugs and Vaccine Revenue, 2023-2028
5.2.3 By Application - Global Neglected Tropical Diseases Drugs and Vaccine Revenue Market Share, 2017-2028
6 Sights by Region
6.1 By Region - Global Neglected Tropical Diseases Drugs and Vaccine Market Size, 2021 & 2028
6.2 By Region - Global Neglected Tropical Diseases Drugs and Vaccine Revenue & Forecasts
6.2.1 By Region - Global Neglected Tropical Diseases Drugs and Vaccine Revenue, 2017-2022
6.2.2 By Region - Global Neglected Tropical Diseases Drugs and Vaccine Revenue, 2023-2028
6.2.3 By Region - Global Neglected Tropical Diseases Drugs and Vaccine Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Neglected Tropical Diseases Drugs and Vaccine Revenue, 2017-2028
6.3.2 US Neglected Tropical Diseases Drugs and Vaccine Market Size, 2017-2028
6.3.3 Canada Neglected Tropical Diseases Drugs and Vaccine Market Size, 2017-2028
6.3.4 Mexico Neglected Tropical Diseases Drugs and Vaccine Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Neglected Tropical Diseases Drugs and Vaccine Revenue, 2017-2028
6.4.2 Germany Neglected Tropical Diseases Drugs and Vaccine Market Size, 2017-2028
6.4.3 France Neglected Tropical Diseases Drugs and Vaccine Market Size, 2017-2028
6.4.4 U.K. Neglected Tropical Diseases Drugs and Vaccine Market Size, 2017-2028
6.4.5 Italy Neglected Tropical Diseases Drugs and Vaccine Market Size, 2017-2028
6.4.6 Russia Neglected Tropical Diseases Drugs and Vaccine Market Size, 2017-2028
6.4.7 Nordic Countries Neglected Tropical Diseases Drugs and Vaccine Market Size, 2017-2028
6.4.8 Benelux Neglected Tropical Diseases Drugs and Vaccine Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Neglected Tropical Diseases Drugs and Vaccine Revenue, 2017-2028
6.5.2 China Neglected Tropical Diseases Drugs and Vaccine Market Size, 2017-2028
6.5.3 Japan Neglected Tropical Diseases Drugs and Vaccine Market Size, 2017-2028
6.5.4 South Korea Neglected Tropical Diseases Drugs and Vaccine Market Size, 2017-2028
6.5.5 Southeast Asia Neglected Tropical Diseases Drugs and Vaccine Market Size, 2017-2028
6.5.6 India Neglected Tropical Diseases Drugs and Vaccine Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Neglected Tropical Diseases Drugs and Vaccine Revenue, 2017-2028
6.6.2 Brazil Neglected Tropical Diseases Drugs and Vaccine Market Size, 2017-2028
6.6.3 Argentina Neglected Tropical Diseases Drugs and Vaccine Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Neglected Tropical Diseases Drugs and Vaccine Revenue, 2017-2028
6.7.2 Turkey Neglected Tropical Diseases Drugs and Vaccine Market Size, 2017-2028
6.7.3 Israel Neglected Tropical Diseases Drugs and Vaccine Market Size, 2017-2028
6.7.4 Saudi Arabia Neglected Tropical Diseases Drugs and Vaccine Market Size, 2017-2028
6.7.5 UAE Neglected Tropical Diseases Drugs and Vaccine Market Size, 2017-2028
7 Players Profiles
7.1 Artecef BV
7.1.1 Artecef BV Corporate Summary
7.1.2 Artecef BV Business Overview
7.1.3 Artecef BV Neglected Tropical Diseases Drugs and Vaccine Major Product Offerings
7.1.4 Artecef BV Neglected Tropical Diseases Drugs and Vaccine Revenue in Global Market (2017-2022)
7.1.5 Artecef BV Key News
7.2 GlaxoSmithKline
7.2.1 GlaxoSmithKline Corporate Summary
7.2.2 GlaxoSmithKline Business Overview
7.2.3 GlaxoSmithKline Neglected Tropical Diseases Drugs and Vaccine Major Product Offerings
7.2.4 GlaxoSmithKline Neglected Tropical Diseases Drugs and Vaccine Revenue in Global Market (2017-2022)
7.2.5 GlaxoSmithKline Key News
7.3 AstraZeneca
7.3.1 AstraZeneca Corporate Summary
7.3.2 AstraZeneca Business Overview
7.3.3 AstraZeneca Neglected Tropical Diseases Drugs and Vaccine Major Product Offerings
7.3.4 AstraZeneca Neglected Tropical Diseases Drugs and Vaccine Revenue in Global Market (2017-2022)
7.3.5 AstraZeneca Key News
7.4 Novartis
7.4.1 Novartis Corporate Summary
7.4.2 Novartis Business Overview
7.4.3 Novartis Neglected Tropical Diseases Drugs and Vaccine Major Product Offerings
7.4.4 Novartis Neglected Tropical Diseases Drugs and Vaccine Revenue in Global Market (2017-2022)
7.4.5 Novartis Key News
7.5 Sanofi-Aventis
7.5.1 Sanofi-Aventis Corporate Summary
7.5.2 Sanofi-Aventis Business Overview
7.5.3 Sanofi-Aventis Neglected Tropical Diseases Drugs and Vaccine Major Product Offerings
7.5.4 Sanofi-Aventis Neglected Tropical Diseases Drugs and Vaccine Revenue in Global Market (2017-2022)
7.5.5 Sanofi-Aventis Key News
7.6 Ranbaxy Labs
7.6.1 Ranbaxy Labs Corporate Summary
7.6.2 Ranbaxy Labs Business Overview
7.6.3 Ranbaxy Labs Neglected Tropical Diseases Drugs and Vaccine Major Product Offerings
7.6.4 Ranbaxy Labs Neglected Tropical Diseases Drugs and Vaccine Revenue in Global Market (2017-2022)
7.6.5 Ranbaxy Labs Key News
7.7 Lupin
7.7.1 Lupin Corporate Summary
7.7.2 Lupin Business Overview
7.7.3 Lupin Neglected Tropical Diseases Drugs and Vaccine Major Product Offerings
7.7.4 Lupin Neglected Tropical Diseases Drugs and Vaccine Revenue in Global Market (2017-2022)
7.7.5 Lupin Key News
7.8 Macleods Pharmaceuticals
7.8.1 Macleods Pharmaceuticals Corporate Summary
7.8.2 Macleods Pharmaceuticals Business Overview
7.8.3 Macleods Pharmaceuticals Neglected Tropical Diseases Drugs and Vaccine Major Product Offerings
7.8.4 Macleods Pharmaceuticals Neglected Tropical Diseases Drugs and Vaccine Revenue in Global Market (2017-2022)
7.8.5 Macleods Pharmaceuticals Key News
7.9 Cipla
7.9.1 Cipla Corporate Summary
7.9.2 Cipla Business Overview
7.9.3 Cipla Neglected Tropical Diseases Drugs and Vaccine Major Product Offerings
7.9.4 Cipla Neglected Tropical Diseases Drugs and Vaccine Revenue in Global Market (2017-2022)
7.9.5 Cipla Key News
7.10 Romark Laboratories
7.10.1 Romark Laboratories Corporate Summary
7.10.2 Romark Laboratories Business Overview
7.10.3 Romark Laboratories Neglected Tropical Diseases Drugs and Vaccine Major Product Offerings
7.10.4 Romark Laboratories Neglected Tropical Diseases Drugs and Vaccine Revenue in Global Market (2017-2022)
7.10.5 Romark Laboratories Key News
7.11 Toyama Chemica
7.11.1 Toyama Chemica Corporate Summary
7.11.2 Toyama Chemica Business Overview
7.11.3 Toyama Chemica Neglected Tropical Diseases Drugs and Vaccine Major Product Offerings
7.11.4 Toyama Chemica Neglected Tropical Diseases Drugs and Vaccine Revenue in Global Market (2017-2022)
7.11.5 Toyama Chemica Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
